144 related articles for article (PubMed ID: 7534896)
1. Histopathologic evaluation of proliferating cell nuclear antigen (PC10) in oral epithelial hyperplasias and premalignant lesions.
Huang WY; Coltrera M; Schubert M; Morton T; Truelove E
Oral Surg Oral Med Oral Pathol; 1994 Dec; 78(6):748-54. PubMed ID: 7534896
[TBL] [Abstract][Full Text] [Related]
2. Markers for dysplasia of the upper aerodigestive tract. Suprabasal expression of PCNA, p53, and CK19 in alcohol-fixed, embedded tissue.
Coltrera MD; Zarbo RJ; Sakr WA; Gown AM
Am J Pathol; 1992 Oct; 141(4):817-25. PubMed ID: 1384338
[TBL] [Abstract][Full Text] [Related]
3. Proliferating cell nuclear antigen in malignant and pre-malignant lesions of epithelial origin in the oral cavity and the skin: an immunohistochemical study.
Tsuji T; Shrestha P; Yamada K; Takagi H; Shinozaki F; Sasaki K; Maeda K; Mori M
Virchows Arch A Pathol Anat Histopathol; 1992; 420(5):377-83. PubMed ID: 1375793
[TBL] [Abstract][Full Text] [Related]
4. Proliferating cell nuclear antigen (PCNA) as a marker of dysplasia in oral mucosa.
Martínez-Lara I; González-Moles MA; Ruiz-Avila I; Bravo M; Ramos MC; Fernández-Martínez JA
Acta Stomatol Belg; 1996 Mar; 93(1):29-32. PubMed ID: 8986050
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies in the diagnosis of epithelial premalignant lesions.
Dabelsteen E; Graem N; Hakomori S; Young WW
Bull Cancer; 1983; 70(2):127-31. PubMed ID: 6871487
[TBL] [Abstract][Full Text] [Related]
6. Expression of the CA1 determinant by carcinomas and by non-malignant epithelial cells in oral lesions.
Shabana AH; Ivanyi L; Kramer IR
Br J Cancer; 1983 Oct; 48(4):527-31. PubMed ID: 6354238
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical expression of metallothionein in benign premalignant and malignant epithelium of the larynx: correlation with p53 and proliferative cell nuclear antigen.
Ioachim E; Assimakopoulos D; Peschos D; Zissi A; Skevas A; Agnantis NJ
Pathol Res Pract; 1999; 195(12):809-14. PubMed ID: 10631715
[TBL] [Abstract][Full Text] [Related]
8. Proliferating cell nuclear antigen (PCNA) and p53 in epithelial dysplasia and squamous cell carcinoma of oral mucosa--a marker for poor tumor differentiation, increasing nuclear atypia and invasiveness?
Lan HA; Zain RB; Saitoh M; Muramatsu Y; Shrestha P; Mori M
Anticancer Res; 1996; 16(5B):3059-65. PubMed ID: 8920767
[TBL] [Abstract][Full Text] [Related]
9. Expression of tumor-associated antigen (DF3) in atypical hyperplasias and in situ carcinomas of the human breast.
Ohuchi N; Page DL; Merino MJ; Viglione MJ; Kufe DW; Schlom J
J Natl Cancer Inst; 1987 Jul; 79(1):109-17. PubMed ID: 3298784
[TBL] [Abstract][Full Text] [Related]
10. Ki-67 Prognostic Value in Different Histological Grades of Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
Takkem A; Barakat C; Zakaraia S; Zaid K; Najmeh J; Ayoub M; Seirawan MY
Asian Pac J Cancer Prev; 2018 Nov; 19(11):3279-3286. PubMed ID: 30486632
[TBL] [Abstract][Full Text] [Related]
11. Sequential increases in proliferating cell nuclear antigen expression in head and neck tumorigenesis: a potential biomarker.
Shin DM; Voravud N; Ro JY; Lee JS; Hong WK; Hittelman WN
J Natl Cancer Inst; 1993 Jun; 85(12):971-8. PubMed ID: 8098774
[TBL] [Abstract][Full Text] [Related]
12. Increase in placental glutathione S-transferase in human oral epithelial dysplastic lesions and squamous cell carcinomas.
Zhang L; Xiao Y; Priddy R
J Oral Pathol Med; 1994 Feb; 23(2):75-9. PubMed ID: 8164157
[TBL] [Abstract][Full Text] [Related]
13. Reactivity of monoclonal antibodies 17.13 and 63.12 with 141 oral mucosal lesions.
Migliorati CA; Ranken R; Kaplan MJ; Silverman S
J Oral Pathol Med; 1992 Oct; 21(9):412-7. PubMed ID: 1279163
[TBL] [Abstract][Full Text] [Related]
14. Premalignant and malignant oral lesions are associated with changes in the glycosylation pattern of carbohydrates related to ABH blood group antigens.
Dabelsteen E; Clausen H; Holmstrup P; Reibel J
APMIS; 1988 Sep; 96(9):813-9. PubMed ID: 3048339
[TBL] [Abstract][Full Text] [Related]
15. Accumulation of a blood group antigen precursor in oral premalignant lesions.
Dabelsteen E; Vedtofte P; Hakomori S; Young WW
Cancer Res; 1983 Mar; 43(3):1451-4. PubMed ID: 6825113
[TBL] [Abstract][Full Text] [Related]
16. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma.
Cruz IB; Snijders PJ; Meijer CJ; Braakhuis BJ; Snow GB; Walboomers JM; van der Waal I
J Pathol; 1998 Apr; 184(4):360-8. PubMed ID: 9664901
[TBL] [Abstract][Full Text] [Related]
17. [Immunopathology of the oral mucosa. Oral immune system--inflammatory reactions--tumor-"marker"--virus identification].
Löning T
Veroff Pathol; 1984; 121():1-178. PubMed ID: 6322469
[TBL] [Abstract][Full Text] [Related]
18. Proliferating cell nuclear antigen in normal urothelium and urothelial lesions of the urinary bladder: a quantitative assessment using a true color image analysis system.
Knuechel R; Burgau M; Rueschoff J; Hofstaedter F
Virchows Arch B Cell Pathol Incl Mol Pathol; 1993; 64(3):137-44. PubMed ID: 7902171
[TBL] [Abstract][Full Text] [Related]
19. [Immunohistochemical study of proliferating cell nuclear antigen (PCNA) in gynecological tumors and their related lesions].
Sawada M; Ueda G; Inoue M; Shimizu H; Ogawa H; Nakazawa A; Fujita M; Tanizawa O; Tsujimoto M
Nihon Sanka Fujinka Gakkai Zasshi; 1992 Feb; 44(2):181-7. PubMed ID: 1347557
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemically stained markers (p53, PCNA, bcl-2) in dysplastic lesions of the larynx.
Krecicki T; Jeleń M; Zalesska-Krecicka M; Szkudlarek T; Szajowski K
Cancer Lett; 1999 Aug; 143(1):23-8. PubMed ID: 10465333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
